Central Europe Advantage Leverage PHARMNET’s Prague base and long-standing site relationships to accelerate patient recruitment and reduce costs in Central Europe, offering sponsors quicker study starts and competitive per-patient pricing.

Regulatory Excellence A proven track record of successful inspections by FDA, MHRA, Health Canada and European regulators provides credibility and reduces regulatory risk for sponsors pursuing global trials.

Full-service Expertise End-to-end capabilities from Phase I through IV plus specialty and stand-alone services (medical device investigations, auditing, protocol design, medical writing, pharmacovigilance) enable cross-selling and a single-point partner for diverse trial needs.

Global Reach and Pricing Serving clients across North America, Europe, Israel and Asia-Pacific with competitive Central European pricing positions PHARMNET to support global programs while optimizing trial economics and timelines.

Tech-Driven Operations A technology-enabled operating model with tools such as iCIMS, Microsoft 365 and analytics platforms supports data integrity and on-time delivery, presenting a modern CRO profile for sponsors prioritizing reliability and scalable processes.